BHIC — what changed in the latest 10-Q
A section-by-section comparison of BHIC's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-07 vs the prior 10-Q · 2026-05-11
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +60 | −28 | ~6 | 8 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3), Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-07
Our net loss for the three months ended June 30, 2026 was $185,753 compared to a net income of $457,704 during the three months ended June 30, 2025. The Company has generated revenue of $1,036,364 and $1,757,463 during the three months ended June 30, 2026 and 2025, respectively. This change is a res…
For the Quarter and Six Months Ended June 30, 2026 (Second Quarter 2026)
The following discussion should be read together with our unaudited financial statements and the related notes. This section contains forward-looking statements that reflect management's current expectations and are subject to risks and uncertainties. Statements regarding markets, valuation, product…
1. Executive Overview — Our Vision: "Ground Zero" Cellular Wellness
BioScience Health Innovations, Inc. ("BHIC," the "Company," "we") is the public-company platform for Best 365 Labs, a foundational-nutrition and cellular-health company. Our thesis is simple and, we believe, differentiated: almost every health journey begins — or should begin — at the cellular level…
Text removed vs the prior filing · source: 10-Q · 2026-05-11
THREE MONTHS ENDED MARCH 31, 2026 COMPARED TO MARCH 31, 2025
Currently, the Company is in the process of offering a private placement to accredited investors to raise up to $1,000,000. Once the private placement is complete the Company will begin the process of preparing and filing Form 1-A with the SEC.
BioScience Health Innovations Inc., through its wholly owned subsidiary Best 365 Labs, Inc., is a biotech and nutraceutical company focused on cellular health optimization, testosterone replacement therapy, and advanced nutrient delivery systems. The Company’s proprietary MODS Max (Mineral Oxide Del…
The Company operates from its headquarters in Bluffdale, Utah, manufactures non-prescription products through CGMP-compliant facilities, and maintains several 503A pharmacy relationships for the production of prescription-related products. BHIC is actively working toward establishing its own 503A co…
a)Flagship product: TPrime365 (MODS Max Gold) — a 4-in-1 sublingual testosterone optimizer containing Enclomiphene (25mg), Spermidine (10mg), Boron (10mg), and Vitamin C (10mg)
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice